Year archive

Pluri Inc. — 2021 filings

All 106 regulatory filings released by Pluri Inc. (PLUR) in 2021, sourced directly from the official regulator.

106 Filings

2021 Period

2021 filings (106)

Filing	Released	Lang
8K- Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19 Regulatory Filings	2021-12-27	English
8K- Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19 Report Publication Announcement	2021-12-27	English
Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19 Regulatory Filings	2021-12-27	English
Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19 Report Publication Announcement	2021-12-27	English
CURRENT REPORT Regulatory Filings	2021-12-27	English
Multinational Phase III study, for the treatment of muscle injury following arthroplasty for hip fracture is fully enrolled with 240 patients Regulatory Filings	2021-11-17	English
Multinational Phase III study, for the treatment of muscle injury following arthroplasty for hip fracture is fully enrolled with 240 patients Regulatory Filings	2021-11-17	English
CURRENT REPORT Regulatory Filings	2021-11-16	English
Completes Enrollment of Its Multinational Phase III Study of Muscle Regeneration Following Hip Fracture Surgery Regulatory Filings	2021-11-15	English
Completes Enrollment of Its Multinational Phase III Study of Muscle Regeneration Following Hip Fracture Surgery Report Publication Announcement	2021-11-15	English
Pluristem Receives Approval for Grant from the Israel Innovation Authority to Develop its Next-Generation CRISPR PLX Platform Regulatory Filings	2021-11-10	English
Pluristem Receives Approval for Grant from the Israel Innovation Authority to Develop its Next-Generation CRISPR PLX Platform Report Publication Announcement	2021-11-10	English
Form 10-Q- FINANCIAL STATEMENTS As of September 30, 2021 Interim / Quarterly Report Q1 2022	2021-11-09	English
Form 10-Q- FINANCIAL STATEMENTS As of September 30, 2021 Report Publication Announcement Q1 2021	2021-11-09	English
QUARTERLY REPORT Interim / Quarterly Report Q1 2022	2021-11-08	English
Other Report or Announcement Legal Proceedings Report	2021-09-22	English
Other Report or Announcement Report Publication Announcement	2021-09-22	English
FORM 10-K For the fiscal year ended June 30, 2021 Annual Report FY 2021	2021-09-14	English
FORM 10-K For the fiscal year ended June 30, 2021 Report Publication Announcement FY 2021	2021-09-14	English
ANNUAL REPORT Annual Report FY 2021	2021-09-13	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Director's Dealing	2021-07-27	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Regulatory Filings	2021-07-27	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Director's Dealing	2021-07-27	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Director's Dealing	2021-07-27	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Major Shareholding Notification	2021-07-27	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2021-07-27	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Major Shareholding Notification	2021-07-27	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Director's Dealing	2021-07-27	English
OWNERSHIP DOCUMENT Director's Dealing	2021-07-26	English
OWNERSHIP DOCUMENT Director's Dealing	2021-07-26	English
Director's Dealing 2021 Director's Dealing	2021-07-26	English
Director's Dealing 2021 Director's Dealing	2021-07-26	English
8k - Appointment of new Directors Board/Management Information	2021-07-19	English
8k - Appointment of new Directors Board/Management Information	2021-07-19	English
Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Directors Board/Management Information	2021-07-19	English
Appoints Prof. Varda Shalev MD and Mr. Doron Birger to Join its Board of Directors Board/Management Information	2021-07-19	English
CURRENT REPORT Regulatory Filings	2021-07-19	English
FORM 8-K-Brings ARDS Associated by with COVID-19 Phase II Studies to Clinical Readout Regulatory Filings	2021-07-08	English
FORM 8-K-Brings ARDS Associated by with COVID-19 Phase II Studies to Clinical Readout Report Publication Announcement	2021-07-08	English
Pluristem Brings ARDS Associated with COVID-19 Phase II Studies to Clinical Readout Regulatory Filings	2021-07-08	English
Pluristem Brings ARDS Associated with COVID-19 Phase II Studies to Clinical Readout Report Publication Announcement	2021-07-08	English
CURRENT REPORT Regulatory Filings	2021-07-08	English
annual shareholders meeting results - June 2, 2021 Declaration of Voting Results & Voting Rights Announcements	2021-06-02	English
annual shareholders meeting results - June 2, 2021 AGM Information	2021-06-02	English
CURRENT REPORT Regulatory Filings	2021-06-02	English
AMENDMENT NO.3 TO SCHEDULE 13G Major Shareholding Notification	2021-06-01	English
Director's Dealing 2021 Director's Dealing	2021-06-01	English
Director's Dealing 2021 Director's Dealing	2021-05-27	English
8K - first tranche of EIB loan Capital/Financing Update	2021-05-25	English
8K - first tranche of EIB loan Report Publication Announcement	2021-05-25	English
Pluristem to Receive €20M Non-Dilutive Funding from the European Investment Bank Capital/Financing Update	2021-05-25	English
Pluristem to Receive €20M Non-Dilutive Funding from the European Investment Bank Regulatory Filings	2021-05-25	English
CURRENT REPORT Regulatory Filings	2021-05-25	English
10Q - March 31, 2021 Interim / Quarterly Report 9M 2021	2021-05-07	English
10Q - March 31, 2021 Report Publication Announcement Q1 2021	2021-05-07	English
QUARTERLY REPORT Interim / Quarterly Report Q3 2021	2021-05-06	English
Director's Dealing 2021 Director's Dealing	2021-05-04	English
Investors Presentation - HCT Topline Results Investor Presentation	2021-05-04	English
Investors Presentation - HCT Topline Results Report Publication Announcement	2021-05-04	English
CURRENT REPORT Regulatory Filings	2021-05-03	English
reports positive topline Phase I results in innovative hematology program, which is first to study PLX-R18 in humans Regulatory Filings	2021-04-29	English
reports positive topline Phase I results in innovative hematology program, which is first to study PLX-R18 in humans Report Publication Announcement	2021-04-29	English
CURRENT REPORT Regulatory Filings	2021-04-29	English
Immediate Report of Meeting to be held on June 1st,2021 Proxy Solicitation & Information Statement	2021-04-12	English
Immediate Report of Meeting to be held on June 1st,2021 AGM Information	2021-04-12	English
ANNUAL MEETING OF STOCKHOLDERS,To Be Held On June 1, 2021 Proxy Solicitation & Information Statement	2021-04-11	English
ANNUAL MEETING OF STOCKHOLDERS,To Be Held On June 1, 2021 AGM Information	2021-04-11	English
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS To Be Held On June 1, 2021 Proxy Solicitation & Information Statement	2021-04-09	English
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS To Be Held On June 1, 2021 Remuneration Information	2021-04-09	English
DEFINITIVE PROXY STATEMENT Proxy Solicitation & Information Statement	2021-04-08	English
8-K - Changes in Registrant's Certifying Accountant Regulatory Filings	2021-03-26	English
8-K - Changes in Registrant's Certifying Accountant Regulatory Filings	2021-03-26	English
CURRENT REPORT Regulatory Filings	2021-03-25	English
Form 10-Q For the quarterly period ended December 31, 2020 Interim / Quarterly Report H1 2021	2021-02-09	English
Form 10-Q For the quarterly period ended December 31, 2020 Report Publication Announcement	2021-02-09	English
QUARTERLY REPORT Interim / Quarterly Report Q2 2021	2021-02-08	English
AMENDMENT NO. 3 TO SCHEDULE 13G Major Shareholding Notification	2021-02-05	English
FORM 8-K, Securities purchase agreement with institutional investors,to issue and sell 4,761,905 shares Regulatory Filings	2021-02-04	English
FORM 8-K, Securities purchase agreement with institutional investors,to issue and sell 4,761,905 shares Report Publication Announcement	2021-02-04	English
PROSPECTUS SUPPLEMENT , FEBRUARY 2,2021 Share Issue/Capital Change	2021-02-04	English
PROSPECTUS SUPPLEMENT , FEBRUARY 2,2021 Report Publication Announcement	2021-02-04	English
CURRENT REPORT Regulatory Filings	2021-02-03	English
PROSPECTUS SUPPLEMENT Prospectus	2021-02-03	English
Announces $30 MillionRegistered Direct Offering Capital/Financing Update	2021-02-02	English
Announces $30 MillionRegistered Direct Offering Report Publication Announcement	2021-02-02	English
Trading in the company's securities was halted until the completion of pricing in U.S. Regulatory Filings	2021-02-02	Hebrew (modern)
Uplisting to the Nasdaq Global Market Regulatory Filings	2021-01-27	English
Uplisting to the Nasdaq Global Market Report Publication Announcement	2021-01-27	English
SC 13G Major Shareholding Notification	2021-01-11	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Levi, Rami Avraham Director's Dealing	2021-01-08	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Levi, Rami Avraham Regulatory Filings	2021-01-08	English
FORM 4-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Levi, Rami Avraham Director's Dealing	2021-01-08	English
FORM 4-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Levi, Rami Avraham Report Publication Announcement	2021-01-08	English
OWNERSHIP DOCUMENT Director's Dealing	2021-01-07	English
Director's Dealing 2021 Director's Dealing	2021-01-07	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Director's Dealing	2021-01-07	English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Regulatory Filings	2021-01-07	English
Director's Dealing 2021 Director's Dealing	2021-01-06	English
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Shemesh-Rasmussen, Maital - Form 3 Major Shareholding Notification	2021-01-06	English
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Shemesh-Rasmussen, Maital - Form 3 Report Publication Announcement	2021-01-06	English
8K-Appointments of Two Directors to Board Board/Management Information	2021-01-06	English
8K-Appointments of Two Directors to Board Board/Management Information	2021-01-06	English
Appointments of Two Directors to Board Board/Management Information	2021-01-06	English
Appointments of Two Directors to Board Report Publication Announcement	2021-01-06	English
Director's Dealing 2021 Director's Dealing	2021-01-06	English
CURRENT REPORT Regulatory Filings	2021-01-06	English

Filings by year

2026 29 filings
2025 186 filings
2024 146 filings
2023 89 filings
2022 102 filings
2021 106 filings
2020 215 filings
2019 136 filings
2018 128 filings
2017 210 filings
2016 182 filings
2015 184 filings
2014 223 filings
2013 172 filings
2012 144 filings
2011 147 filings
2010 50 filings
2009 57 filings
2008 37 filings
2007 35 filings
2006 32 filings
2005 34 filings
2004 32 filings
2003 38 filings
2002 10 filings
2001 2 filings